[Lance Sherriff assisted in the transcription and compilation of this article.] Fatty liver disease (hepatic steatosis) was found to be very common among people living with HIV in a cross-sectional study involving 160 people on antiretroviral treatment, according to data presented at the 9th International HIV and Aging Workshop last week in New York …
[Lance Sherriff assisted in the transcription and compilation of this article.] Mitochondria (the small organelles in cells that are critical for energy production) within the muscle fibers of antiretroviral-treated people living with HIV may be significantly damaged, according to a study presented last week in New York at the HIV and Aging Workshop by researchers …
Even newer NRTIs (anti-HIV drugs) found to cause mitochondrial damage in muscle Read More »
Many of the aging people living with HIV suffering the most may not be able to defend themselves. Key points: An ACT UP working group is starting to compile a list of HIV care facilities with experience treating long-term survivors and people living with HIV over the age of 50 who are experiencing aging-related …
Last week, two members of ACT UP NY came to the general meeting to tell us about a crisis that has befallen, by their estimation, a few dozen older HIV+ clients who were receiving care from an HIV-specialist named Olivieri based in Manhattan who was arrested a few months back. Dr. Olivieri’s practice specialized in …
Frailty, the condition of depleted energy and physiological decline that is often seen in the elderly and that makes them less capable of recovering from illness, accidents and the stresses of life, has been reported to be significantly more common in people living with HIV — even in middle-aged people on antiretroviral treatment (ART) …
The high risk of frailty in middle-aged people living with HIV Read More »
Last week, I retweeted a press release from the NIH about a presentation that Tony Fauci was going to make at the AIDS Conference, which featured the lead quote “Durable control of HIV infection in the absence of antiretroviral therapy is a feasible concept that deserves vigorous pursuit.” This was referring to the ‘cure’ …
TB2016 was a two-day conference dedicated exclusively to TB that immediately preceded the 21st International AIDS Conference (AIDS 2016) in Durban, South Africa. It convened TB implementers, TB scientists, infectious disease clinicians and scientists, health policy makers, and advocacy — but was held in conjunction with AIDS2016 in the hope that it would attract many …
In the last 16 years, countries in sub-Saharan Africa have created the largest treatment programs in the world; their activists negotiated access and prices globally in its courts; and their implementers have provided the innovations in delivery to ensure coverage at community level. This is not just reflected in treatment numbers (10.7 million) but in …
AIDS 2016: Bringing treatment programmes to scale in Africa Read More »
Due to family and personal health issues, as well as our work and residences changing, this site became inactive approximately three and a half years ago. We’d like to have a more formal relaunch soon and to begin to cover stories from conferences and the medical literature again on a more regular basis. In …
Treatment Science Writers site starting up again… Read More »
Results of the United Kingdom PROUD study were published in the September 9th issue of the Lancet, following their earlier presentation at the Conference on Retroviruses and Opportunistic Infections 2015, in Seattle [1]. As reported at CROI, pre-exposure prophylaxis (PrEP) dramatically reduces the risk of HIV infection in gay men and transgender females by …